Associated Papers
Spontaneous final adult height in patients with idiopathic short stature.
Banaszak-Ziemska M et al.
Pediatric Endocrinology, Diabetes, and Metabolism, 2025
Genetic analysis of the PAPP-A2 gene and evaluation of free IGF-1, IGFBP-5, and ALS concentrations in a group of 22 patients with idiopathic short stature.
Banaszak-Ziemska M et al.
Endokrynologia Polska, 2024
Cryo-EM structure of human PAPP-A2 and mechanism of substrate recognition.
Sridar J et al.
Communications Chemistry, 2023
Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency.
Muthuvel G et al.
Hormone Research in Paediatrics, 2023
Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.
Barrios V et al.
Cells, 2021
Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects.
Fujimoto M et al.
Molecular and Cellular Endocrinology, 2020
Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation.
Fujimoto M et al.
Endocrinology, 2019
Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density.
Cabrera-Salcedo C et al.
The Journal of Clinical Endocrinology and Metabolism, 2017
One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology.
Argente J et al.
Embo Molecular Medicine, 2017
Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.
Dauber A et al.
Embo Molecular Medicine, 2016
Select a paper to view details